Cognitive Existential Therapy for men with early stage prostate cancer and their partners

Not Applicable

• Conditions: prostate cancer; coping; depression; anxiety; Mental Health - Depression; Cancer - Prostate

• Registration Number: ACTRN12609000534280
• Lead Sponsor: Dr Jeremy Couper

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. couples must have been married or living together for at least 12 months
2. one partner must have histologically confirmed early stage prostate cancer
3. the diagnosis of prostate cancer must have been made no more than 12 months prior to the date of recruitment
4. both partners must be able to commit to 6 sessions of Cognitive Existential Couples Therapy
5. both partners must be able to read and write English

Exclusion Criteria

1. presence of domestic violence
2. long-standing, intractible relationship difficulties
3. severe substance abuse in either partner
4. severe psychotic illness, dementia or intellectual disability in either partner
5. active suicidal ideation in either partner
6. another type of active cancer in either partner
7. another severely dibilitating or life-threatening illness requiring active treatment in either partner

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
level of psychological distress (scores on Mental Health Inventory and Impact of Events Scale-Revised)[at baseline, immediately post intervention and at 6 and 26 weeks post intervention]

Secondary Outcome Measures

Name	Time	Method
quality or relating (scores on Family (Couples) Relationship Index and Cancer Support Inventory)[at baseline, immediately post intervention and at 6 and 26 weeks post intervention];level of coping (scores on Brief COPE and Benefit Finding Scale)[at baseline, immediately post intervention and at 6 and 26 weeks post intervention]